Updated on 11 Oct 2026, 09:11 PM IST
|
| ||||
|
| ||||
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,756.90 | 0.25 | 4,21,529.23 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 9,326.00 | -0.67 | 2,47,575.99 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,660.00 | -0.32 | 1,77,245.08 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,303.30 | -0.13 | 1,05,288.19 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,115.10 | -0.01 | 1,11,231.65 | 21.19 | 4.24 | 0.09 | 14.22 |
| Meeting Date | Purpose |
|---|---|
| 2026-05-12 | Audited Results, Dividend & Others |
| 2025-10-14 | Quarterly Results & Others |
| 2025-08-22 | Dividend & Others |
| 2025-05-29 | To Consider Fund Raising & Other |
| 2025-05-09 | Audited Results & Others |
Accent Microcell is trading at 646.25 as on Fri Oct 09 2026 09:53:41. This is 0.10% upper as compared to its previous closing price of 645.60.
The market capitalization of Accent Microcell is 1550.29 Cr as on Fri Oct 09 2026 09:53:41.
The 52 wk high for Accent Microcell is 731.70 whereas the 52 wk low is 238.00
Accent Microcell can be analyzed on the following key metrics -
Accent Microcell reported a net profit of 87.72 Cr in 2026.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.